# Sangamo Therapeutics, Inc: filings

SGMOQ · OTC · CIK 1001233 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sgmoq.md) · [Financials](/companies/sgmoq/financials.md) · [Filings](/companies/sgmoq/filings.md) · [Insiders](/companies/sgmoq/insiders.md)

## Reports and events: 298 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 618, 8-K 199, 10-Q 52, SC 13G/A 49, 3 36, CT ORDER 31, 424B5 21, 10-K 18, 4/A 17, DEF 14A 17, SC 13G 15, S-8 14, DEFA14A 11, 5 10, CORRESP 8, EFFECT 8, 8-K/A 7, UPLOAD 7, POS AM 5, PRE 14A 5, S-8 POS 5, S-3 4, SCHEDULE 13G/A 4, 10-K/A 3, ARS 3, S-3ASR 3, 144 2, DEFR14A 2, FWP 2, POSASR 2, SC 13D/A 2, 25-NSE 1, 3/A 1, NT 10-Q 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 17:33 ET | [8-K](/filings/0001193125-26-423054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-423054 |
| 2026-09-21 | 16:01 ET | [8-K](/filings/0001193125-26-396644.md) | 1.03 Bankruptcy or receivership; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-396644 |
| 2026-09-08 | 16:06 ET | [8-K](/filings/0001104659-26-105905.md) | 1.03 Bankruptcy or receivership; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105905 |
| 2026-08-28 | 16:05 ET | [8-K](/filings/0001193125-26-374328.md) | 1.01 Entry into a material agreement; 1.03 Bankruptcy or receivership; 9.01 Financial statements and exhibits | 0001193125-26-374328 |
| 2026-08-13 | 21:36 ET | [8-K](/filings/0001193125-26-347524.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347524 |
| 2026-08-12 | 16:02 ET | [8-K](/filings/0001193125-26-346796.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-346796 |
| 2026-07-20 | 16:44 ET | [8-K](/filings/0001193125-26-309012.md) | 1.03 Bankruptcy or receivership; 3.01 Delisting notice | 0001193125-26-309012 |
| 2026-07-01 | 16:01 ET | [8-K](/filings/0001193125-26-292501.md) | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-292501 |
| 2026-06-23 | 16:42 ET | [8-K/A](/filings/0001193125-26-279630.md) | 9.01 Financial statements and exhibits | 0001193125-26-279630 |
| 2026-06-23 | 08:45 ET | [8-K](/filings/0001193125-26-278582.md) | 1.01 Entry into a material agreement; 1.03 Bankruptcy or receivership; 2.03 New direct financial obligation; 2.05 Exit or disposal costs | 0001193125-26-278582 |
| 2026-05-14 | 16:03 ET | [10-Q](/filings/0001628280-26-035067.md) | Quarterly report, period 2026-03-31 | 0001628280-26-035067 |
| 2026-05-14 | 16:02 ET | [8-K](/filings/0001628280-26-035061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-035061 |
| 2026-04-30 | 19:34 ET | [10-K/A](/filings/0001628280-26-028524.md) | Annual report, amended, period 2025-12-31 | 0001628280-26-028524 |
| 2026-04-29 | 08:37 ET | [8-K](/filings/0001628280-26-028128.md) | 3.01 Delisting notice | 0001628280-26-028128 |
| 2026-03-30 | 17:31 ET | [10-K](/filings/0001628280-26-022029.md) | Annual report, period 2025-12-31 | 0001628280-26-022029 |
| 2026-03-30 | 17:29 ET | [8-K](/filings/0001628280-26-022006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-022006 |
| 2026-02-04 | 08:35 ET | [8-K](/filings/0001193125-26-036792.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-036792 |
| 2026-02-03 | 16:07 ET | [8-K](/filings/0001001233-26-000005.md) | 8.01 Other events | 0001001233-26-000005 |
| 2026-02-03 | 08:55 ET | [8-K](/filings/0001001233-26-000002.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001001233-26-000002 |
| 2025-11-06 | 08:07 ET | [10-Q](/filings/0001001233-25-000024.md) | Quarterly report, period 2025-09-30 | 0001001233-25-000024 |
| 2025-11-06 | 08:05 ET | [8-K](/filings/0001001233-25-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001001233-25-000023 |
| 2025-10-29 | 16:08 ET | [8-K](/filings/0001001233-25-000015.md) | 3.01 Delisting notice | 0001001233-25-000015 |
| 2025-09-30 | 16:01 ET | [8-K](/filings/0001001233-25-000013.md) | 5.02 Departure or appointment of officers or directors | 0001001233-25-000013 |
| 2025-09-11 | 17:00 ET | [8-K](/filings/0001001233-25-000011.md) | 5.02 Departure or appointment of officers or directors | 0001001233-25-000011 |
| 2025-09-04 | 08:06 ET | [8-K](/filings/0001001233-25-000006.md) | 8.01 Other events | 0001001233-25-000006 |
| 2025-08-07 | 16:05 ET | [10-Q](/filings/0001628280-25-038860.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038860 |
| 2025-08-07 | 16:02 ET | [8-K](/filings/0001628280-25-038855.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038855 |
| 2025-06-24 | 08:08 ET | [8-K](/filings/0001628280-25-032748.md) | 8.01 Other events | 0001628280-25-032748 |
| 2025-06-16 | 16:06 ET | [8-K](/filings/0001628280-25-031559.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-031559 |
| 2025-05-13 | 17:21 ET | [8-K](/filings/0001140361-25-018697.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-018697 |
| 2025-05-12 | 16:01 ET | [10-Q](/filings/0001628280-25-024650.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024650 |
| 2025-05-06 | 16:03 ET | [8-K](/filings/0001628280-25-022664.md) | 3.01 Delisting notice | 0001628280-25-022664 |
| 2025-04-30 | 17:35 ET | [DEF 14A](/filings/0001628280-25-020773.md) | Proxy statement, period 2025-06-12 | 0001628280-25-020773 |
| 2025-03-17 | 16:05 ET | [10-K](/filings/0001628280-25-013088.md) | Annual report, period 2024-12-31 | 0001628280-25-013088 |
| 2025-03-17 | 16:01 ET | [8-K](/filings/0001628280-25-013085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-013085 |
| 2025-02-06 | 08:13 ET | [8-K](/filings/0001628280-25-004197.md) | 8.01 Other events | 0001628280-25-004197 |
| 2024-12-30 | 16:23 ET | [8-K](/filings/0001628280-24-052579.md) | 1.02 Termination of a material agreement | 0001628280-24-052579 |
| 2024-12-10 | 21:27 ET | [8-K](/filings/0001628280-24-050545.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-050545 |
| 2024-11-12 | 16:02 ET | [10-Q](/filings/0001628280-24-047102.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047102 |
| 2024-11-12 | 16:01 ET | [8-K](/filings/0001628280-24-047099.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047099 |
| 2024-10-04 | 16:03 ET | [8-K](/filings/0001628280-24-042308.md) | 7.01 Regulation FD disclosure | 0001628280-24-042308 |
| 2024-08-06 | 16:02 ET | [10-Q](/filings/0001628280-24-035165.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035165 |
| 2024-08-06 | 16:01 ET | [8-K](/filings/0001628280-24-035160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035160 |
| 2024-07-24 | 16:05 ET | [8-K](/filings/0001628280-24-032815.md) | 8.01 Other events | 0001628280-24-032815 |
| 2024-06-05 | 17:10 ET | [8-K](/filings/0001628280-24-026903.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-026903 |
| 2024-05-09 | 16:04 ET | [10-Q](/filings/0001628280-24-022194.md) | Quarterly report, period 2024-03-31 | 0001628280-24-022194 |
| 2024-05-09 | 16:01 ET | [8-K](/filings/0001628280-24-022186.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-022186 |
| 2024-04-30 | 16:02 ET | [8-K](/filings/0001628280-24-019337.md) | 3.01 Delisting notice | 0001628280-24-019337 |
| 2024-04-19 | 16:01 ET | [DEF 14A](/filings/0001628280-24-016932.md) | Proxy statement, period 2024-06-04 | 0001628280-24-016932 |
| 2024-03-25 | 17:04 ET | [8-K](/filings/0001193125-24-076613.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-076613 |

Page 1 of 6. [Older](/companies/sgmoq/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.